financetom
Business
financetom
/
Business
/
Meta fixes error that flooded Instagram Reels with violent videos
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Meta fixes error that flooded Instagram Reels with violent videos
Feb 27, 2025 5:06 AM

(Reuters) - Meta Platforms ( META ) said on Thursday it had resolved an error that flooded the personal Reels feeds of Instagram users with violent and graphic videos worldwide.

It was not immediately clear how many people were affected by the glitch. Meta's comments followed a wave of complaints on social media about violent and "not safe for work" content in Reels feeds, despite some users having enabled the "sensitive content control" setting meant to filter such material.

"We have fixed an error that caused some users to see content in their Instagram Reels feed that should not have been recommended. We apologize for the mistake," a spokesperson for Meta said.

It did not disclose the reason behind the error.

Meta's moderation policies have come under scrutiny after it decided last month to scrap its U.S. fact-checking program on Facebook, Instagram and Threads, three of the world's biggest social media platforms with more than 3 billion users globally.

Violent and graphic videos are prohibited under Meta's policy and the company usually removes such content to protect users, barring exceptions given for videos that raise awareness on topics including human rights abuse and conflict.

The company has in recent years been leaning more on its automated moderation tools, a tactic that is expected to accelerate with the shift away from fact-checking in the United States.

Meta has faced criticism for failing to effectively balance content recommendations and user safety, as seen in incidents like the spread of violent content during the Myanmar genocide, Instagram promoting eating disorder content to teens and misinformation during the COVID-19 pandemic.

(Reporting by Surbhi Misra and Akash Sriram in Bengaluru; Editing by Saumyadeb Chakrabarty)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved